EUVIMEDEUVIMED entdecken
Crossref

Dual‐Integrin‐Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy

Bowen Li, Jianwei Bao, Yan Huang, Jikang Liu, Xuehai Yan iD, Qianli Zou iD

Small · 2025

DOI: 10.1002/smll.202409038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Bowen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei, 230032, China. Hauptthemen laut MEDLINE: Peptides, Liver, Integrins, Liver Cirrhosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Research Community Science Fund of China, Anhui Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of integrin‐binding peptides within self‐assembling building blocks is crucial for the development of targeted nanoarchitectonics. However, such constructs typically incorporate only a single integrin‐binding peptide, limiting their multifunctionality. Herein, a rationally designed self‐assembling peptide with dual integrin‐binding motifs for α5β1 and αvβ3 is presented. This peptide forms highly ordered nanofibers or nanoparticles (VH‐NPs) with tailored secondary structures. In vitro and in vivo studies demonstrate that VH‐NPs target activated hepatic stellate cells via dual‐integrin interactions, enabling selective targeting to fibrotic livers and suppressing α5β1 and αvβ3. Notably, VH‐NPs can encapsulate rhein through noncovalent interactions, resulting in peptide‐rhein nanoarchitectonics that display augmented antifibrotic effects. These findings highlight the potential of self‐assembling peptides that leverage multiple targets and therapeutic modules as a promising strategy for constructing multifunctional nanoarchitectonics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesLiverIntegrinsLiver CirrhosisDrug Delivery SystemsAntifibrotic AgentsAnimalsNanofibersHumansHepatic Stellate CellsNanoparticlesMiceIntegrin alphaVbeta3Integrin alpha5beta1

Stichwörter der Autor:innen

antifibrotic therapyhepatic deliverynanoarchitectonicspeptidesrhein

Substanzen

PeptidesIntegrinsIntegrin alphaVbeta3Integrin alpha5beta1Antifibrotic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China.
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, 230061, China.

ORCID-Profile: Xuehai Yan, Qianli Zou

Förderung

  • National Natural Science Foundation of China
  • Innovation Research Community Science Fund of China
  • Anhui Provincial Natural Science Foundation
  • Hefei Municipal Natural Science Foundation
  • Research Improvement Program of Anhui Medical University
  • University Synergy Innovation Program of Anhui Province
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Li, B., Bao, J., Huang, Y., Liu, J., Yan, X., & Zou, Q. (2025). Dual‐Integrin‐Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy. Small. https://doi.org/10.1002/smll.202409038

Vancouver

Li B, Bao J, Huang Y, Liu J, Yan X, Zou Q. Dual‐Integrin‐Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy. Small. 2025. doi:10.1002/smll.202409038

BibTeX
@article{Li2025,
  author = {Li, Bowen and Bao, Jianwei and Huang, Yan and Liu, Jikang and Yan, Xuehai and Zou, Qianli},
  title = {Dual‐Integrin‐Targeted Supramolecular Peptide Nanoarchitectonics for Enhanced Hepatic Delivery and Antifibrotic Therapy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202409038}
}
Kostenlos starten →